ImmunoGen
IMGN
#1887
Rank
โ‚น735.95 B
Marketcap
โ‚น2,635
Share price
0.00%
Change (1 day)
137.04%
Change (1 year)

Revenue for ImmunoGen (IMGN)

Revenue in 2023 (TTM): โ‚น23.76 Billion

According to ImmunoGen 's latest financial reports the company's current revenue (TTM ) is โ‚น24.26 Billion. In 2022 the company made a revenue of โ‚น9.00 Billion an increase over the revenue in the year 2021 that were of โ‚น5.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunoGen from 1996 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น23.76 B163.95%
2022 โ‚น9.00 B73.13%
2021 โ‚น5.19 B-46.26%
2020 โ‚น9.67 B64.92%
2019 โ‚น5.86 B56.99%
2018 โ‚น3.73 B-49.3%
2017 โ‚น7.37 B
2015 โ‚น3.78 B-19.48%
2014 โ‚น4.69 B-0.09%
2013 โ‚น4.70 B565.36%
2012 โ‚น0.70 B-38.91%
2011 โ‚น1.15 B68.46%
2010 โ‚น0.68 B-21%
2009 โ‚น0.86 B-47.63%
2008 โ‚น1.65 B6.95%
2007 โ‚น1.55 B-6.72%
2006 โ‚น1.66 B15.43%
2005 โ‚น1.44 B-4.79%
2004 โ‚น1.51 B180.36%
2003 โ‚น0.53 B45.57%
2002 โ‚น0.37 B43.98%
2001 โ‚น0.25 B-27.4%
2000 โ‚น0.35 B-17.55%
1999 โ‚น0.43 B912.19%
1998 โ‚น42.52 M170.48%
1997 โ‚น15.71 M9.32%
1996 โ‚น14.38 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น194.05 B 699.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.744 T 11,211.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.447 T 14,107.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.001 T 16,392.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.397 T 30,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.693 T 19,246.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.212 T 17,263.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น4.513 T 18,503.80%๐Ÿ‡ซ๐Ÿ‡ท France